01 1Fine Chemicals Corporation (PTY) Ltd.
02 1Benechim
03 2Apothecon Pharmaceuticals Pvt Ltd
04 1DISHMAN CARBOGEN AMCIS LIMITED
05 1Edmond Pharma Srl
06 1Jubilant Pharmova Limited
07 1SMS Lifesciences India Limited
08 2Shandong Anhong Pharmaceutical Co., Ltd.
09 1Siegfried Evionnaz SA
10 1Spectrum Laboratory Products, Inc.
01 1Palbociclib
02 1ROPIVACAINE
03 1ROPIVACAINE HYDROCHLORIDE
04 2Ropivacaine HCl
05 4Ropivacaine Hydrochloride
06 2Ropivacaine Hydrochloride Monohydrate
07 1ropivacaine hydrochloride
01 2China
02 5India
03 1South Africa
04 1Spain
05 1Sweden
06 1Switzerland
07 1U.S.A
NDC Package Code : 48954-722
Start Marketing Date : 2009-11-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53335-0003
Start Marketing Date : 2021-03-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61876-0071
Start Marketing Date : 2010-12-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1159
Start Marketing Date : 2011-09-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66583-0610
Start Marketing Date : 1998-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49386-022
Start Marketing Date : 2019-08-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49386-025
Start Marketing Date : 2019-08-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17381-506
Start Marketing Date : 2010-05-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72375-0004
Start Marketing Date : 2020-12-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-6303
Start Marketing Date : 2019-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Ropivacaine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ropivacaine HCl, including repackagers and relabelers. The FDA regulates Ropivacaine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ropivacaine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ropivacaine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ropivacaine HCl supplier is an individual or a company that provides Ropivacaine HCl active pharmaceutical ingredient (API) or Ropivacaine HCl finished formulations upon request. The Ropivacaine HCl suppliers may include Ropivacaine HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Ropivacaine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ropivacaine HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ropivacaine HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ropivacaine HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ropivacaine HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ropivacaine HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ropivacaine HCl suppliers with NDC on PharmaCompass.
We have 10 companies offering Ropivacaine HCl
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?